Difficulty: Medium
Average Score: 75%
Practice
BetaÔéé agonists (e.g. salbutamol, terbutaline, salmeterol):
Correct answer
A
Rationale
The correct answer is A) Relax bronchial smooth muscle.
BetaÔéé agonists like salbutamol, terbutaline, and salmeterol are used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These medications work by binding to betaÔéé-adrenergic receptors in the bronchial smooth muscle, leading to the relaxation of the muscle. This action results in bronchodilation, which helps to alleviate symptoms of bronchoconstriction and improve airflow in the lungs.
Option B) Inhibit release of mast cell and other inflammatory mediators is incorrect because betaÔéé agonists do not directly inhibit the release of inflammatory mediators. Instead, they primarily target the smooth muscle of the airways to promote bronchodilation.
Option C) Reduce heart rate is incorrect because betaÔéé agonists mainly affect the respiratory system by targeting the bronchial smooth muscle and do not have a significant impact on heart rate.
Option D) Cause pulmonary vasoconstriction is incorrect because betaÔéé agonists actually cause vasodilation in the pulmonary circulation, which can be beneficial in conditions like pulmonary hypertension.
Understanding the mechanism of action of betaÔéé agonists is crucial for healthcare professionals managing patients with respiratory conditions. It is essential to know how these drugs work to ensure safe and effective treatment. By correctly identifying the action of betaÔéé agonists, healthcare providers can optimize therapy and improve patient outcomes.
BetaÔéé agonists like salbutamol, terbutaline, and salmeterol are used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These medications work by binding to betaÔéé-adrenergic receptors in the bronchial smooth muscle, leading to the relaxation of the muscle. This action results in bronchodilation, which helps to alleviate symptoms of bronchoconstriction and improve airflow in the lungs.
Option B) Inhibit release of mast cell and other inflammatory mediators is incorrect because betaÔéé agonists do not directly inhibit the release of inflammatory mediators. Instead, they primarily target the smooth muscle of the airways to promote bronchodilation.
Option C) Reduce heart rate is incorrect because betaÔéé agonists mainly affect the respiratory system by targeting the bronchial smooth muscle and do not have a significant impact on heart rate.
Option D) Cause pulmonary vasoconstriction is incorrect because betaÔéé agonists actually cause vasodilation in the pulmonary circulation, which can be beneficial in conditions like pulmonary hypertension.
Understanding the mechanism of action of betaÔéé agonists is crucial for healthcare professionals managing patients with respiratory conditions. It is essential to know how these drugs work to ensure safe and effective treatment. By correctly identifying the action of betaÔéé agonists, healthcare providers can optimize therapy and improve patient outcomes.